Cargando…
Atypical femoral fracture in a multiple myeloma patient undergoing treatment with denosumab: A case report and literature review
INTRODUCTION AND IMPORTANCE: Denosumab is a new standard treatment for bone disease caused by multiple myeloma. There are a few reports of atypical femoral fracture in patients with multiple myeloma, all of which were associated with long-term use of bisphosphonate. Here, we report the first case of...
Autores principales: | Omichi, Yasuyuki, Toki, Shunichi, Nishisho, Toshihiko, Harada, Takeshi, Sato, Nori, Sairyo, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382856/ https://www.ncbi.nlm.nih.gov/pubmed/37421768 http://dx.doi.org/10.1016/j.ijscr.2023.108456 |
Ejemplares similares
-
Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma Developed in a Patient with Progressive Muscular Dystrophy: A Case Report and Review of the Literature
por: Miyagi, Ryo, et al.
Publicado: (2017) -
Denosumab and atypical femoral fractures
por: Aspenberg, Per
Publicado: (2014) -
Combination chemotherapy of doxorubicin and ifosfamide with proton beam therapy for myoepithelial carcinoma originating in the paraspinal region: A case report and literature review
por: Toki, Shunichi, et al.
Publicado: (2022) -
Blue light induces apoptosis and autophagy by promoting ROS‐mediated mitochondrial dysfunction in synovial sarcoma
por: Takeuchi, Makoto, et al.
Publicado: (2023) -
Atypical femoral fractures bilaterally in a patient receiving denosumab
por: Drampalos, Efstathios, et al.
Publicado: (2014)